Brett Fried, DPM
Foot & Ankle Surgery · Royal Palm Beach, FLNPI 1932167335
Payments from drug & device makers
Across 359 payments — averaging $41.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6K
- Integra Lifesciences Corporation$2K
- Amgen$1K
- Biocomposites Inc$920
- Treace Medical Concepts, Inc.$577
- Organogenesis Inc.$557
- plus $3K from 22 others
What the payments were for
- Food & beverage$14,67498%
- Other$2652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 83 | $6,197 |
| Integra Lifesciences Corporation | 38 | $2,360 |
| Amgen(2 entities) | 89 | $1,004 |
| Biocomposites Inc | 8 | $920 |
| Treace Medical Concepts, Inc. | 16 | $577 |
| Organogenesis Inc. | 15 | $557 |
| Flower Orthopedics Coporation | 9 | $553 |
| DJO, LLC | 5 | $439 |
| Cardiovascular Systems Inc. | 3 | $390 |
| Abbott | 3 | $322 |
| Paratek Pharmaceuticals, Inc. | 49 | $294 |
| Fusion Orthopedics USA, LLC | 2 | $231 |
| Smith+Nephew | 10 | $189 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $151 |
| ANI Pharmaceuticals, Inc. | 4 | $136 |
| Johnson & Johnson | 3 | $112 |
| Cook Medical LLC | 1 | $112 |
| Sebela Pharmaceuticals Inc. | 4 | $75 |
| Vilex LLC | 1 | $49 |
| ETS Wound Care LLC | 2 | $45 |
| Acera Surgical, Inc. | 2 | $42 |
| Orthofix Medical, Inc. | 2 | $39 |
| Linvatec Corporation | 1 | $39 |
| Kerecis Limited | 2 | $35 |
| Anika Therapeutics, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Merck | 1 | $16 |
| Acell, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$2,879
- PRIMATRIX$1,080
- INTEGRA DERMAL REGENERATION TEMPLATE$1,080
- Stimulan$746
- VARIAX$700
- PROLAYER$484
- GRAFTJACKET$418
- ASNIS$400
- PuraPly$339
- ESPRIT$266
- ACell$265
- CMF OL1000$245
- PROstep$152
- KRYSTEXXA$150
- AXSOS$143
- ALLOMATRIX$129
- Lapiplasty System$127
- JUBLIA$125
- ALLOWRAP$125
- INTEGRA MESHED BILAYER WOUND MATRIX$120
How this compares
$14,939 in reported general payments places this provider in the 80th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 28 | $17,768 |
| JubliaEfinaconazole | 13 | $9,822 |
| Ciclopirox | 64 | $1,778 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 81 | $1,374 |
| Mupirocin | 118 | $843 |
| Methylprednisolone | 105 | $648 |
| Gabapentin | 78 | $535 |
| Meloxicam | 131 | $384 |
| Cephalexin | 24 | $311 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $194 |
| Celecoxib | 15 | $101 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $93 |
| Ciprofloxacin Hcl | 13 | $89 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $189 | $17,76828 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $151 | $9,82213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Royal Palm Beach
- Daniel ElgutRoyal Palm Beach$73K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.